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Protein kinase CThe inhibition of the complex III of the mitochondrial respiratory chain under hypoxia-ischemia has been
observed. However, the downstream events of this inhibition remain to be studied. In this paper, we used the
Qi site inhibitor antimycin A and the Qo site inhibitor myxothiazol to inhibit the Qi site and the Qo site of the
complex III and studied the effect and mechanism of the inhibition of these sites on voltage-gated Ca2+
currents (ICa) in rat prefrontal neurons with whole cell patch-clamp method in slices. The results showed
that antimycin A inhibited ICa, but myxothiazol increased it. Further mechanism study showed that
antimycin A inhibited ICa via the H2O2-hydroxyl radicals/cPKC (mainly PKCβI) pathway, whereas
myxothiazol increased ICa via the superoxide anion/nPKC (mainly the PKCδ) pathway.Medical Neurobiology, Fudan
ad, Shanghai, 200032, People's
64174579.
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Mitochondria play a central role in the survival and death of
neurons. Under physiological and pathophysiological conditions, a
number of changes to mitochondrial function have been observed.
Among them, it has been proposed that the inhibition of mitochon-
drial respiration is one of the earliest events occurring in ischemic
tissue [1–3]. The inhibition of the complex I, complex II, complex III
and complex IV of themitochondrial respiratory chain under hypoxia-
ischemia has been observed [4–11], especially the inhibition of the
complex III has received considerable attention because the complex
III has a special electron transfer pathway [12] and the consequence of
its inhibition may be complicated. However, the downstream events
of the inhibition of the complex III remain to be studied.
The complex III is a complex of membrane proteins, consisting of
11 different polypeptides [13]. There are two centers in the complex
III: the Qo center, where ubiquinol is oxidized; and the Qi center,
where ubisemiquinone is reduced [14]. Using the Qi site inhibitor
antimycin A to mimic the complex III response to hypoxia, Chandel et
al studied the downstream event of the inhibition of the Qi site of the
complex III and found that antimycin A could lead to the stabilization
of the hypoxia-inducible factor-1α [15]. Another downstream event
of the inhibition of the Qi site of the complex III from our previousstudy was that it could lead to a decrease in both transient and
persistent sodium currents and thus inhibit neuronal excitability [16].
In addition, our previous study found that the inhibition of the Qo site
of the complex III with the Qo site inhibitor myxothiazol could
increase the persistent sodium currents and the neuronal excitability
[17]. However, the downstream events of the inhibition of the Qi and
Qo site of the complex III may be more complicated because the
products of the inhibition of these two sites are reactive oxygen
species (ROS), which may have multiple potential targets. In this
paper, we used antimycin A and myxothiazol to inhibit the Qi and Qo
site, respectively and studied the effects and mechanism of the
inhibition of these two sites on voltage-gated Ca2+ channels in rat
prefrontal neurons with whole cell patch-clampmethod in slices. This
investigation is of signiﬁcant importance because the voltage-gated
Ca2+ channels have been known to play important roles in the
survival of neurons under hypoxia.
2. Materials and methods
2.1. Preparation of cortical slices
14- to 20 day-old Sprague-Dawley rats were anesthetized with
chloral hydrate (400 mg/kg, i.p.). All experimental procedures
conformed to Fudan University as well as the international guidelines
on the ethical use of animals and all efforts were made to minimize
the number of the animals used and their suffering. Slices were
prepared according to the procedures described previously [18].
Brieﬂy, after the rat was decapitated, the brain was quickly excised
and immersed in the ice-cold artiﬁcial cerebrospinal ﬂuid (ACSF)
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1.25 mM NaH2PO4, 26 mM NaHCO3, 10 mM glucose, 10 mM sucrose
and saturated with 95% O2/5% CO2. A block of tissue containing the
medial prefrontal cortex (mPFC) was cut and placed on a layer of
moistened ﬁlter paper glued to the cutting stage of a vibratome
(VT1000M/E, Leica, Wetzlar, Germany). Coronal slices (380 μm)were
cut and then transferred into an incubating chamber (30-32 °C)
where they stayed for at least one hour before recordings began.
2.2. Visualization of pyramidal cells
To visualize the cell, the slice was placed in a recording chamber
and viewed with a ﬁxed stage, upright microscope equipped with
Nomarski optics and a 40X water immersion objective (Olympus,
Tokyo, Japan). To increase the clarity of the image, the infrared light
was used to illuminate the slice. The resultant infrared DIC
(differential interference contrast) images were visualized on a
black-white TV monitor through the use of a low light sensitive CCD
camera. Recordings were made from pyramidal cells of the mPFC.
Pyramidal cells were identiﬁed by their pyramidal shape and the
presence of the apical dendrite.
2.3. Whole cell recordings
The slice was continuously perfused with the ACSF. Electrodes
were pulled from glass capillaries using a Narishige micropipetter
puller (model PB-7, Narishige, Japan). They had a resistance of 4-6 MΩ
when ﬁlled with the patch pipette solution containing 135 mM CsCl,
2 mMMgCl2·6H2O, 0.1 mM CaCl2, 1 mM EGTA, 2 mM ATP-K2, 0.1 mM
GTP-Na3, 10 mM HEPES, pH adjusted to 7.4 by CsOH. To record Ca2+
currents, the external ﬂuid was changed to the solution containing:
110 mM NaCl, 5 mM KCl, 5 mM BaCl2, 2 mM MgCl2·6H2O, 10 mM
glucose, 1.25 mM NaH2PO4, 26 mM NaHCO3, 5 mM 4-AP, 10 mM
TEA·Cl, pH adjusted to 7.4. Ba2+ was substituted for Ca2+ as the
charge carrier in order to reduce problems associated with the voltage
clamping of large Ca2+ currents [19]. Under these recording
conditions, depolarizations of 500 ms in duration from -60 to 40 mV
in 10 mV increments from a holding potential of -70 mVwere applied
to activate the voltage-gated Ca2+ currents (ICa). The current-voltage
relationship of ICa recorded here was similar to those reported by
other authors [20]. ICa were obvious at the potential of -30 mV, peaked
at the potential of -10 mV and reversed at the potential around
+30 mV (n=6). ICa were further demonstrated by the experiment
that the voltage-gated Ca2+ channel blocker cadmium (100 μM) could
completely abolish these currents (n=8). The current signals were
recorded with an Axopatch 200B ampliﬁer (Axon, Union City, USA)
connected to a Digidata1200 interface (Axon, Union City, USA). The
data were digitized and stored on disks using pClamp (Axon, Union
City, USA). All experiments were conducted at room temperature
(21–24 °C).
2.4. Data analysis
Statistical signiﬁcance between two groups was evaluated by
Student's two-tailed t test. The signiﬁcance of the differences between
multiple groups at different time-points was evaluated by one-way
ANOVA with a post hoc Tukey test. All values were expressed as
means±standard errors of means (SEM) and the number of cells (n)
in each group was given.
2.5. Drugs
ATP·K2, GTP·Na3, CsOH, CdCl2, tetraethylammonium (TEA), 4-
aminopyridine (4-AP), antimycin A, myxothiazol, 1,10 phenanthro-
line (PHEN), 2-mercaptopropionylglycine (MPG), superoxide
dismutase (SOD), chelerythrine, 3-{1-[3-(amidinothio) propyl]-1H-indoyl-3-yl}-3-(1-methyl-1H-indoyl-3-yl) maleimide methane sulfo-
nate (RO318220), 5,6-bis[(4-ﬂuorophenyl)amino]-1H-isoindole-1,3
(2H)-dione (CGP53353), rottlerin, bryostatin and thymeleatoxin
were purchased from Sigma. Mn(III) tetrakis (4-benzoic acid)
porphyrin (MnTBAP) was from Calbiochem. Tetrodotoxin (TTX) was
made in the Research Institute of the Aquatic Products of Hebei. Other
reagents in AR grade were products of Shanghai Chemical Plant. All
drugs were dissolved in dH2O, except for antimycin A, myxothiazol,
PHEN, chelerythrine, CGP53353 and bryostatin, which were dissolved
in DMSO. When DMSO was used as vehicle, drugs were initially
dissolved in 100% DMSO and then diluted into the ACSF at a ﬁnal
DMSO concentration of 0.1%. In vehicle control experiments, we
conﬁrmed that the ﬁnal concentration of DMSO (0.1%) in the ACSF had
no detectable effects on the Ca2+ currents we observed. Antimycin A,
myxothiazol, PHEN, MPG, SOD, chelerythrine, RO318220, CGP53353,
rottlerin, bryostatin, thymeleatoxin, MnTBAP and TTX were applied
by bath perfusion.
3. Results
3.1. Antimycin A decreases the peak amplitude of ICa, but myxothiazol
increases it
Addition of antimycin A and myxothiazol into the bath solution
produced an opposite effect on the peak amplitude of ICa in cortical
neurons. As shown in the left panels of Fig. 1, antimycin A (3 μM)
signiﬁcantly decreased the peak amplitude of ICa. The averaged peak
amplitude of ICa was reduced from 621.7±43.7 pA before antimycin A
to 371.8±27.8 pA at 4 min after antimycin A (n=6, Pb0.05). The
time course showed that the effect of antimycin A became apparent at
1.5 min (Pb0.05) after antimycin A and persisted throughout the rest
of the experiment. We also analyzed the voltage dependence of the
effect of antimycin A on ICa by constructing the current-voltage
relationship of ICa before and after antimycin A. The result showed
that the inhibitory effect of antimycin A was obvious when the
membrane potential was depolarized to the range between -30 mV
and +10 mV. The maximal inhibition percentage was 51.5% at the
potential of -20 mV. However, myxothiazol (5 μM) signiﬁcantly
increased the peak amplitude of ICa (the right panels of Fig. 1). The
averaged peak amplitude of ICa was increased from 614.1±43.7 pA
before myxothiazol to 802.3±42.4 pA at 4 min after myxothiazol
(n=6, Pb0.05). The time course showed that the effect of
myxothiazol appeared at 2 min (Pb0.05) after myxothiazol and
persisted throughout the rest of the experiment. The experiment of
the voltage dependence of the effect of myxothiazol showed that
myxothiazol was effective when the membrane potential was within
the range between -30 mV and +10 mV. The maximal potentiation
percentage was 52.6 % at the membrane potential of -30 mV.
3.2. Roles of oxidants in the effects of antimycin A and myxothiazol on ICa
To test the roles of oxidants in the effects of antimycin A and
myxothiazol on ICa, we observed the inﬂuence of the antioxidant
PHEN and MPG on the effects of antimycin A and myxothiazol. The
results showed that PHEN (10 μM) orMPG (300 μM) could abolish the
inhibitory effect of antimycin A on ICa (Fig. 2A and B, n=6), but could
not abolish the potentiation effect of myxothiazol on ICa (Fig. 2C and
2D, n=6). MPG or PHEN alone had no effects on ICa (n=6). In
addition, H2O2 (100 μM) could mimic the effect of antimycin A on ICa
(Fig. 3). The averaged peak amplitude of ICa was reduced from 601.5±
49.6 pA before H2O2 to 369.8±39.4 pA at 4 min after H2O2 (n=6,
Pb0.05, compared to control). However, the superoxide scavengers
SOD (10 U/ml) and MnTBAP (10 μM) could cancel the potentiation
effect of myxothiazol on ICa (Fig. 4A and B, n=6). SOD or MnTBAP
alone had no effect on ICa (n=6). We also observed the inﬂuence of
MnTBAP on the effect of antimycin A. The result showed that MnTBAP
Fig. 1. Effect of antimycin A andmyxothiazol on ICa in cortical neurons. A: raw data before and 4 min after antimycin A (3 μM). Holding potential: -70 mV. B: the averaged amplitude of ICa
before and 4 minafter antimycinA (3 μM).n=6, *Pb0.05, compared to control. C: the time courseof the antimycinA (3 μM)effect. n=6, *Pb0.05, compared to control before antimycinA.
D: the averaged current-voltage relationship for the amplitude of ICa from6 cells before and 4 min after antimycinA (3 μM). E: rawdata before and 4 min aftermyxothiazol (5 μM).Holding
pestilential: -70 mV. F: the averaged amplitude of ICa before and 4 min aftermyxothiazol (5 μM). n=6, *Pb0.05, compared to control. G: the time course of themyxothiazol (5 μM) effect.
n=6, *Pb0.05, compared to control before myxothiazol. H: the averaged current-voltage relationship for the amplitude of ICa from 6 cells before and 4 min after myxothiazol (5 μM).
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Fig. 2. Inﬂuence of the antioxidant PHEN and MPG on the effect of antimycin A andmyxothiazol on ICa in cortical neurons. A and B: inﬂuence of PHEN (10 μM) andMPG (300 μM) on
the effect of antimycin A (3 μM) on ICa. n=6, *Pb0.05, compared to PHEN or MPG before antimycin A; #Pb0.05, compared to antimycin A alone. C and D: inﬂuence of PHEN (10μM)
and MPG (300 μM) on the effect of myxothiazol (5 μM) on ICa. n=6, *Pb0.05, compared to PHEN or MPG before myxothiazol.
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antimycin A on ICa (Fig. 4C, n=6).3.3. Roles of protein kinase C (PKC) in the effects of antimycin A and
myxothiazol on ICa
To test the role of PKC in the effects of antimycin A and
myxothiazol on ICa, we observed the inﬂuence of the PKC inhibitor
chelerythrine [21] on the effects of antimycin A and myxothiazol. The
results showed that in the presence of chelerythrine (2.5 μM), the
effects of both antimycin A and myxothiazol disappeared (Fig. 5A
and B, n=6). Chelerythrine alone had no effects on ICa (n=6).
To examine which subtypes of PKC were responsible for the effect
of antimycin A and myxothiazol on ICa, we observed the inﬂuence ofFig. 3. Effect of H2O2 on ICa in cortical neurons. A: raw data before and 4 min after H2O2
(100 μM). Holding potential: -70 mV. B: the averaged amplitude of ICa before and 4 min
after H2O2 (100 μM). n=6, *Pb0.05, compared to control. C: the time course of the
H2O2 (100 μM) effect. n=6, *Pb0.05, compared to control before H2O2.the selective PKC subtype inhibitors on the effect of antimycin A and
myxothiazol. We ﬁrst observed the inﬂuence of RO318220, a PKC
inhibitor that was selective for the classical PKC isoforms (includingα,
βI, βII and γ subtypes) [22], on the effect of antimycin A and
myxothiazol. As shown in Fig. 6, RO318220 (3 μM) could abolish the
effect of antimycin A (Fig. 6A, n=6), but had no inﬂuence on the
effect of myxothiazol (Fig. 6B, n=6). RO318220 alone had no effects
on ICa (n=6).
Next, we examined the inﬂuence of the PKCβ-speciﬁc inhibitor
CG53353 (IC50 value for PKCβII was 0.41 μM and for PKCβI was
3.8 μM) [23] on the effect of antimycin A on ICa. First, we used this
compound at 4 μM to inhibit both PKCβII and PKCβI. The result
showed that in the presence of CGP53353 (4 μM), the effect of
antimycin A disappeared (Fig. 7A, n=6). However, when we used
0.5 μMCGP53353, which was selective for PKCβII [24], we did not ﬁnd
a signiﬁcant inﬂuence of CGP53353 on the effect of antimycin A
(Fig. 7B, n=6). CGP53353 ( 4 μM and 0.5 μM) alone had no effects on
ICa (n=6).
When we examined the inﬂuence of rottlerin (5 μM), which was
selective for PKCδ (One isoform of the novel PKC) [25], on the effect of
myxothiazol, we found that rottlerin (5 μM) could abolish the effect of
myxothiazol on ICa (Fig. 8A, n=6), whereas it had no inﬂuence on the
effect of antimycin A on ICa (Fig. 8B, n=6). Rottlerin (5 μM) alone had
no effects on ICa (n=6).
We also examined the effect of the classical PKC activator
thymeleatoxin [26] and the PKCδ activator bryostatin [27] on ICa.
The result showed that thymeleatoxin (100 nM) and bryostatin
(100 nM) could mimic the effect of antimycin A and myxothiazol on
ICa, respectively. The averaged peak amplitude of ICa was decreased
from 644.3±27.5 pA before thymeleatoxin to 407.4±33.8 pA at
4 min after thymeleatoxin (Fig. 9A, n=6, Pb0.05), whereas the
averaged peak amplitude of ICa was increased from 638.7±30.8 pA
before bryostatin to 812.1±33.9 pA at 4 min after bryostatin (Fig. 9B,
n=6, Pb0.05).
4. Discussion
One of the main ﬁndings of the present study is that the Qi site
inhibitor antimycin A inhibits the amplitude of ICa, but the Qo inhibitor
myxothiazol increases it. To our knowledge, this is the ﬁrst report
about the opposite effect of the inhibition of these two sites on ICa.
We further explored the signaling pathways that connected the
inhibition of these two sites to the changes in ICa. Both antimycin A
and myxothiazol are highly selective inhibitors of the mitochondrial
complex III. In our previous study, using the method described by
Balijepalli et al [28], we conﬁrmed that antimycin A and myxothiazol
indeed could inhibit the activity of the complex III. The activity of
complex III was reduced by 20.0±4.6% and 17.0±2.8% (n=5) in
response to 3 μM antimycin A and 5 μM myxothiazol, respectively.
These results are consistent with those reported for the antimycin
A-induced inhibition (32.2±6.8%) [29] of the complex III and the
ischemia-induced inhibition (22%) [30] of the complex III. More-
over, the binding site of antimycin A and myxothiazol in the
complex III has been studied by structure-activity analysis using
either synthetic analogues of the inhibitors or resistant mutants
of the protein [31–36] and by X-ray crystallography [37,38].
These studies clearly demonstrated that antimycin A targeted
speciﬁcally the Qi site of the complex III, whereas myxothiazol
targeted speciﬁcally the Qo site of the complex III. However, as
analyzed by the following discussion, the signaling pathways that
connect the inhibition of the Qi and Qo site to ICa are different and
thus the inﬂuence of the inhibition of these two sites on ICa is
opposite.
It has been known that the action of antimycin A is to block
speciﬁcally the electron transfer from heme bL to ubisemiquinone in
the Qi site [39] and increases the formation of ubisemiquinone radical,
Fig. 4. Inﬂuence of superoxide scavengers on the effect of myxothiazol and antimycin A on ICa in cortical neurons. A and B: inﬂuence of the superoxide scavengers SOD (10 U/ml) and
MnTBAP (100 μM) on the effect of myxothiazol (5 μM) on ICa. n=6, #Pb0.05, compared to myxothiazol alone. C: inﬂuence of MnTBAP (100 μM) on the effect of antimycin A (3 μM)
on ICa. n=6, *Pb0.05, compared to MnTBAP before antimycin A.
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antimycin A produces its effect on ICa by ROS. This hypothesis is
conﬁrmed by the present results that the antioxidant MPG or PHEN
can completely abolish the effect of antimycin A on ICa. Moreover, we
propose that among different ROS, H2O2may play an important role in
the antimycin A-induced inhibition of ICa. The evidence supporting
this statement is (1) since the Qi site is oriented toward the
mitochondrial matrix [40,41] where there are high levels of Mn-
superoxide dismutase that can transfer the entered superoxide anion
into H2O2 [42], H2O2 should be one of the major products after the
inhibition of the Qi site by antimycin A. This statement has been
demonstrated by the study from Chen et al [43]; (2) exogenous
application of H2O2 can mimic the effect of antimycin A on ICa (the
present result). However, it appears that H2O2 needs to have access toheme Fe2+ to be converted to hydroxyl radicals in the Fenton reaction.
The evidence supporting this statement is (1) PHEN, as a metal
chelator, can chelate iron effectively and thus act as a powerful
antioxidant due to its inhibition of iron-catalyzed Fenton reaction [44].
So the present result that PHEN can cancel the effect of antimycin A on
IC suggests that the produced H2O2 needs heme Fe2+ to be converted
to hydroxyl radicals; (2) although MPG, as a thiol group–containing
compound, can react with all reactive oxygen species, it has a
preference for hydroxyl radicals in its scavenging action [45,46]. Thus,
the present result that MPG can cancel the effect of antimycin A on ICa
suggests that hydroxyl radicals may play an important role in the
effect of antimycin A on ICa.
However, it appears that the Qo inhibitor myxothiazol produces
the increasing effect on ICa via another ROS pathway. In the Qo site,
Fig. 5. Inﬂuence of the wide spectrum PKC inhibitor chelerythrine on the effect of antimycin A and myxothiazol on ICa in cortical neurons. A: inﬂuence of chelerythrine (2.5 μM) on
the effect of antimycin A (3 μM) on ICa. n=6, #Pb0.05, compared to antimycin A alone. B: inﬂuence of chelerythrine (2.5 μM) on the effect of myxothiazol (5 μM) on ICa. n=6,
#Pb0.05, compared to myxothiazol alone.
Fig. 6. Inﬂuence of the cPKC inhibitor RO318220 on the effect of antimycin A andmyxothiazol on ICa in cortical neurons. A: inﬂuence of RO318220 (3 μM)on the effect of antimycin A (3 μM)on
ICa. n=6, #Pb0.05, compared to antimycin A alone. B: inﬂuence of RO318220 (3 μM) on the effect of myxothiazol (5 μM) on ICa. n=6, *Pb0.05, compared to RO318220 before myxothiazol.
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Fig. 7. Inﬂuence of the cPKCβ inhibitor CG53353 (4 μM) and the cPKCβII inhibitor CG53353 (0.5 μM) on the effect of antimycin A on ICa in cortical neurons. A: inﬂuence of CG53353
(4 μM) on the effect of antimycin A (3 μM) on ICa. n=6, #Pb0.05, compared to antimycin A alone. B: inﬂuence of CG53353 (0.5 μM) on the effect of antimycin A (3 μM) on ICa. n=6,
*Pb0.05, compared to CG53353 before antimycin A.
Fig. 8. Inﬂuence of the PKCδ inhibitor rottlerin on the effect of antimycin A and myxothiazol on ICa in cortical neurons. A: inﬂuence of rottlerin (5 μM) on the effect of myxothiazol on ICa.
n=6, #Pb0.05, compared to myxothiazol alone. B: inﬂuence of rottlerin (5 μM) on the effect of antimycin A (3μM) on ICa. n=6, *Pb0.05, compared to rottlerin before antimycin A.
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Fig. 9. Effect of the cPKC activator thymeleatoxin (100 nM) and the nPKCδ activator
bryostatin (100 nM) on ICa in cortical neurons. n=6, *Pb0.05, compared to control.
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to the Rieske iron–sulfur cluster (ISP) and the bL heme (Fig. 10).
The binding site of myxothiazol in the Qo site has been examined
by a number of studies. Brasseur et al proposed that the
myxothiazol binding pocket was underneath the cd helices of
cytochrome b [47]. Using X-ray crystallography analysis Zhang et al
also proposed that the myxothiazol binding site was at the site
from which the electron transfer from the ubisemiquinone to the
bL heme occurred [48]. With the analysis of the absorption
spectrum of bL heme and ISP, it was shown that myxothiazol
caused solely a red-shift of the bL heme's spectrum [49]. Thus, for
the bifurcated electron transfer path in the Q0 site, myxothiazol
blocks the electron transfer from the ubisemiquinone to the bL
heme. Thus, after the binding of myxothiazol, one electron still
moves to ISP, but the pathway of another electron from the
ubisemiquinone to the bL heme is blocked, so resulting in the
formation of ubisemiquinone radicals, which then leave the Qo site
and generate superoxide anion. Moreover, since the x-ray structure
of the complex III reveals that the Qo site is oriented toward the
intermembrane space [40,41], the superoxide anion generated at
this site can move easily into the cytoplasm [50]. This statement
has been conﬁrmed by the result that myxothiazol can promote the
release of the superoxide anion from the mitochondria into the
cytoplasm [51–53]. Therefore, it is likely that myxothiazol produces
the increasing effect on ICa by the superoxide anion. This
hypothesis is conﬁrmed by our results that the superoxide
scavenger MnTBAP and SOD can completely abolish the effect of
myxothiazol. Moreover, our results suggested that it was the
superoxide anion itself rather than the H2O2 and hydroxyl radicals
that mediated the effect of myxothiazol on ICa because MPG and
PHEN had no inﬂuence on the effect of myxothiazol.Although myxothiazol is a potent inhibitor of the complex III, it
has also been found to inhibit the activity of the complex I [54]. This
ability of myxothiazol can potentially complicate interpretation of
results as the complex I [55] is also a source of ROS production.
However, since the NADH dehydrogenase site of electron leak from
the complex I [56] is located in the matrix side of the inner
mitochondrial membrane [57], the superoxide anion production
from the complex I is directed into the mitochondrial matrix, where
the produced superoxide anion is transferred into H2O2 by Mn-
superoxide dismutase. So, even though some ROS was produced due
to an inhibition of the complex I by myxothiazol, the ROS entering
from the mitochondria into the cytoplasm was H2O2, rather than
superoxide anion.
It has been known that ROS can activate PKC [58–62]. Therefore, it
is possible that the activation of PKC is involved in the effect of
antimycin A and myxothiazol on ICa. To test this hypothesis, we
observed the inﬂuence of the wide spectrum PKC inhibitor cheler-
ythrine on the effect of antimycin A and myxothiazol. The result
showed that in the presence of chelerythrine the effect of both
antimycin A and myxothiazol disappeared, suggesting that the
activation of PKC played a key role in the effects of antimycin A and
myxothiazol on ICa. However, since the effects of antimycin A and
myxothiazol on ICa are opposite, we hypothesize that antimycin A
and myxothiazol may produce an opposite effect on ICa via activating
different PKC isozymes.
PKC family includes at least 12 isozymes, which are classiﬁed
into three major groups [63]. The ﬁrst group is the conventional
PKC (cPKC), which includes α, βI, βII and γ types. The second
group, called the novel PKC (nPKC), includes δ, ε, η and θ type. The
third group is the atypical PKC (aPKC), including ζ and λ type. To
test the role of different PKC isozymes in the effect of antimycin A
and myxothiazol on ICa, we observed the inﬂuence of the selective
PKC isozyme inhibitors on the effect of antimycin A and
myxothiazol. The results showed that the cPKC inhibitor could
abolish the effect of antimycin A, but had no inﬂuence on the effect
of myxothiazol; the cPKCβ inhibitor could abolish the effect of
antimycin A, but the cPKCβII inhibitor had no inﬂuence; the nPKCδ
inhibitor could abolish the effect of myxothiazol, but had no
inﬂuence on the effect of antimycin A. These results suggest that
the cPKC (mainly the cPKCβI) plays a key role in the inhibitory
effect of antimycin A on ICa, whereas the nPKC (mainly the nPKCδ)
plays a key role in the increasing effect of myxothiazol on ICa. This
statement was further supported by our results that the cPKC
activator could mimic the inhibitory effect of antimycin A on ICa,
whereas the nPKCδ activator could mimic the increasing effect of
myxothiazol on ICa.
In conclusion, the Qi site inhibitor antimycin A inhibited ICa, but the
Qo site inhibitor myxothiazol increased it; antimycin A inhibited ICa
via the H2O2-hydroxyl radicals/cPKC (mainly cPKCβI) pathway,
whereas myxothiazol increased ICa via the superoxide anion/nPKC
(mainly the nPKCδ) pathway (Fig. 10).
Signiﬁcance – The present ﬁndings are of important signiﬁcance
for revealing the signal transduction pathways that connect the
inhibition of the Qo and Qi site to voltage-gated Ca2+ channels. This
ﬁnding may also provide some evidence for the possible functional
signiﬁcance of the inhibition of the complex III under hypoxia-
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Fig. 10. Schematic representation of the signaling pathways that connect the inhibition of the Qi site by antimycin A and the inhibition of the Qo site by myxothiazol to ICa in cortical
neurons. QH2: ubiquinol; ISP: Rieske iron–sulfur cluster; MYX: myxothiazol; ANT: antimycin A.
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